Oct 8, 2026 09:03AM
Aug 17, 2026 07:12AM
Aug 13, 2026 07:32AM
Jun 24, 2026 07:30AM
Jun 8, 2026 06:11AM
Jun 4, 2026 07:05AM
Jun 4, 2026 03:09AM RBC Capital Downgrades ADC Therapeutics (ADCT) to Sector Perform
May 4, 2026 07:31AM
May 1, 2026 04:57AM
Mar 23, 2026 06:46AM
Mar 10, 2026 07:35AM
Feb 23, 2026 07:15AM
Dec 3, 2025 01:43PM
Nov 12, 2025 06:47AM Guggenheim Reiterates Buy Rating on ADC Therapeutics (ADCT)
Nov 10, 2025 07:31AM
Oct 16, 2025 06:44AM
Oct 1, 2025 06:54AM
Aug 12, 2025 07:33AM
Jun 20, 2025 09:50AM
Jun 16, 2025 07:15AM
Jun 13, 2025 07:16AM ADC Therapeutics (ADCT) PT Raised to $10 at Guggenheim
Jun 12, 2025 06:46AM
Jun 12, 2025 06:30AM
May 14, 2025 04:36PM
May 14, 2025 07:46AM
Apr 12, 2025 04:00AM
Mar 31, 2025 06:54AM
Mar 28, 2025 10:41AM RBC Capital on ADC Therapeutics (ADCT): 'A Critical Year Ahead for Zynlonta Expansion De-Risking'
Mar 27, 2025 07:37AM
Feb 24, 2025 06:52AM
Jan 6, 2025 07:10AM
Dec 11, 2024 07:31AM
Nov 7, 2024 07:33AM
Aug 6, 2024 04:29PM
Jun 27, 2024 07:15AM ADC Therapeutics (ADCT) to Join Russell 2000 and Russell 3000 Indexes

483,942 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All